Disease | osteoporosis |
Phenotype | C0035435|rheumatic diseases |
Sentences | 3 |
PubMedID- 24324644 | Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis. |
PubMedID- 24261336 | Exclusion criteria were patients in need of surgical treatment, cauda equina syndrome, and symptomatic spinal deformities, osteoporosis with fractures, inflammatory rheumatic diseases, other serious somatic or mental diseases, pregnancy, legal labour dispute, and insufficient norwegian language to fill in the questionnaires. |
PubMedID- 20406615 | Objectives: in the 18 month "alendronate or alfacalcidol in glucocorticoid-induced osteoporosis"-trial (stop-trial) patients with rheumatic diseases who started glucocorticoids were randomised to anti-osteoporosis therapy with either daily alendronate (10 mg) or alfacalcidol (1 microg). |
Page: 1